Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 AUD | -3.23% | -9.09% | -26.83% |
Feb. 22 | PharmX Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 11.95M 7.79M | Sales 2023 | 6.13M 3.99M | Capitalization | 22.1M 14.41M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -1M -652K | EV / Sales 2022 | 1.24 x |
Net cash position 2022 | 5.43M 3.54M | Net cash position 2023 | 12.77M 8.33M | EV / Sales 2023 | 1.52 x |
P/E ratio 2022 |
85.2
x | P/E ratio 2023 |
-20.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.97% |
1 week | -9.09% | ||
Current month | -3.23% | ||
3 months | -16.67% | ||
6 months | -30.23% | ||
Current year | -26.83% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.03 | -3.23% | 286,950 |
24-04-17 | 0.031 | -3.13% | 190,759 |
Delayed Quote Australian S.E., April 21, 2024 at 08:15 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.60% | 409B | |
+12.57% | 144B | |
+19.74% | 103B | |
+14.17% | 82.83B | |
+53.81% | 55.78B | |
+29.55% | 51.21B | |
+3.38% | 37.55B | |
+14.29% | 32.28B | |
-11.88% | 22.42B |
- Stock Market
- Equities
- PHX Stock
- PHX Stock